Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats

Neurotoxicity Research

Volumn 19, Issue 4, 2011, Pages 527-535

  Miwa, Clivia Pazin ^a   De Lima, Maria Noêmia Martins ^a,c   Scalco, Felipe ^a   Vedana, Gustavo ^a   Mattos, Raquel ^a   Fernandez, Liana Lisboa ^a,b   Hilbig, Arlete ^b   Schröder, Nadja ^a,c   Vianna, Monica R M ^a,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Federal Foundation School of Medical Sciences   (Brazil)

^c National Institute for Translational Medicine INCT TM   (Brazil)

Author keywords

Aging; Apoptosis; Iron; Neurodegeneration; Rat

Indexed keywords

CASPASE 3; IRON; PROTEINASE ACTIVATED RECEPTOR 4;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DISEASE ASSOCIATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRON OVERLOAD; MALE; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS REGULATORY PROTEINS; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CASPASE 3; CEREBRAL CORTEX; DENTATE GYRUS; FEMALE; IRON, DIETARY; NERVE DEGENERATION; PREGNANCY; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 79958107465     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-010-9181-3     Document Type: Article

References (56)

1. Adams JD, Mukherjee SK, Klaidman LK, Chang ML, Yasharel R (1996) Apoptosis and oxidative stress in the aging brain. Ann N Y Acad Sci 786:135-151 (Pubitemid 26273160)
2. Anglade P, Vyas S, Hirsch EC, Agid Y (1997) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 12(3):603-610 (Pubitemid 27314689)
3. Barja G (2004) Free radicals and aging. Trends Neurosci 10:595-600
4. Chan SL, Tammariello SP, Estus S, Mattson MP (1999) Prostate apoptosis response-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondrial dysfunction and caspase activation. J Neurochem 73(2):502-512 (Pubitemid 29339822)
5. Connor JR, Pavlick G, Karli D, Menzies SL, Palmer C (1995) A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355(1):111-123
6. Dal-Pizzol F, Klamt F, Frota ML Jr, Andrades ME, Caregnato FF, Vianna MM et al (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Brain Res Dev Brain Res 130(1):109-114 (Pubitemid 32830978)
7. de Lima MN, Polydoro M, Laranja DC, Bonatto F, Bromberg E, Moreira JC, Dal-Pizzol F, Schröder N (2005a) Recognition memory impairment and brain oxidative stress by postnatal iron administration. Eur J Neurosci 21:2521-2528 (Pubitemid 40813933)
8. de Lima MN, Laranja DC, Caldana F, Grazziotin MM, Garcia VA, Dal-Pizzol F, Bromberg E, Schröder N (2005b) Selegiline protects against recognition memory impairments induced by neonatal iron treatment. Exp Neurol 196:177-183 (Pubitemid 41416659)
9. de Lima MN, Laranja DC, Caldana F, Bromberg E, Roesler R, Schröder N (2005c) Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp Gerontol 40:506-511 (Pubitemid 40884503)
10. de Lima MN, Presti-Torres J, Caldana F, Grazziotin MM, Scalco FS, Guimarães MR et al (2007) Desferoxamine reverses neonatal iron-induced recognition memory impairment in rats. Eur J Pharmacol 570:111-114 (Pubitemid 47247692)
11. de Lima MN, Presti-Torres J, Garcia VA, Guimarães MR, Scalco FS, Roesler R, Schröder N (2008) Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats. Neuropharmacology 55:788-792
12. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt4):1953-1975
13. Dorszewska J, Adamczewska-Goncerzewicz Z, Szczech J (2004) Apoptotic proteins in the course of aging of central nervous system in the rat. Respir Physiol Neurobiol 139(2):145-155 (Pubitemid 38281118)
14. Duan W, Rangnekar VM, Mattson MP (1999) Par-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J Neurochem 72(6):2312-2322 (Pubitemid 29242181)
15. Dwork AJ, Lawler G, Zybert PA, Durkin M, Osman M, Willson N et al (1990) An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res 518(1-2):31-39 (Pubitemid 20197027)
16. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424 (Pubitemid 29449198)
17. Eichenbaum H (2004) Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 44:109-120
18. El-Guendy N, Rangnekar VM (2003) Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp Cell Res 283(1):51-66 (Pubitemid 36259895)
19. Fernandez LL, Carmona M, Portero-Otin M, Naudi A, Pamplona R, Schröder N et al (2009) Effects of increased iron intake during the neonatal period on the brain of adult AbetaPP/PS1 transgenic mice. J Alzheimers Dis 19:1069-1080
20. Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T (1999) Neonatal iron exposure induces neurobehavioural in adult mice. Toxicol Appl Pharmacol 159(1):25-30 (Pubitemid 29404758)
21. Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T (2000) Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res 119(1):65-74 (Pubitemid 30058383)
22. Friedlander RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348:1365-1375
23. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW et al (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 4(8):957-962 (Pubitemid 28364038)
24. Guo Q, Xie J, Chang X, Zhang X, Du H (2001) Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation. Brain Res 903(1-2):13-25 (Pubitemid 32904602)
25. Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF (1995) The role of transition metals in the pathogenesis of Parkinson's disease. J Neurol Sci 134:69-78
26. Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M (2006) Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 28(2):125-141
27. Lacelle C, Xu S, Wang E (2002) Identification of high caspase-3 mRNA expression as a unique signature profile for extremely old individuals. Mech Ageing Dev 123(8):1133-1144 (Pubitemid 34603097)
28. Lee DW, Andersen JK, Kaur D (2006) Iron dysregulation and neurodegeneration: the molecular connection. Mol Interven 6(2):89-97
29. Lynch AM, Lynch MA (2001) The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci 15(11):1779-1788 (Pubitemid 35471902)
30. Mansour H, Chamberlain CG, Weible MW II, Hughes S, Chu Y, Chan-Ling T (2008) Aging-related changes in astrocytes in the rat retina: imbalance between cell proliferation and cell death reduces astrocyte availability. Aging Cell 7(4):526-540 (Pubitemid 351998613)
31. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1(2):120-129
32. Mattson MP, Kroemer G (2003) Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9(5):196-205 (Pubitemid 36713389)
33. Mattson MP, Duan W, Chan SL, Camandola S (1999) Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders. J Mol Neurosci 13(1-2):17-30 (Pubitemid 30101997)
34. McKay SE, Purcell AL, Carew TJ (1999) Regulation of synaptic function by neurotrophic factors in vertebrates and invertebrates: implications for development and learning. Learn Mem 6(3):193-215 (Pubitemid 29422824)
35. Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science 278(5337):412-419 (Pubitemid 27454417)
36. Paxinos G, Watson C (2005) The rat brain:in stereotaxic coordinates, 6th edn. Academic Press, San Diego
37. Polla AS, Polla LL, Polla BS (2003) Iron as the malignant spirit in successful ageing. Ageing Res Rev 2(1):25-37 (Pubitemid 37443916)
38. Reichmann H, Janetzky B, Riederer P (1995) Iron-dependent enzymes in Parkinson's disease. J Neural Transm Suppl 46:157-164 (Pubitemid 26046557)
39. Rohn TT (2008) Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Brain Res 1228:189-198
40. Salvesen GS (2002) Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 9(1):3-5
41. Schipper HM (2004) Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3(3):265-301
42. Schröder N, Fredriksson A, Vianna MRM, Roesler R, Izquierdo I, Archer T (2001) Memory deficits in adult rats following post natal iron administration. Behav Brain Res 124:77-85 (Pubitemid 32567561)
43. Sells SF, Wood DP Jr, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA et al (1994) Commonality of the gene programs induced by effectors of apoptosis in androgen dependent and independent prostate cells. Cell Growth Differ 5(4):457-466 (Pubitemid 24251397)
44. Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Biophys Res Commun 256(2):381-384 (Pubitemid 29298894)
45. Stefanis L (2005) Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11(1):50-62
46. Swaiman KF (1991) Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 48(12):1285-1293
47. Taglialatela G, Gegg M, Perez-Polo JR, Williams LR, Rose GM (1996) Evidence for DNA fragmentation in the CNS of aged Fischer-344 rats. Neuroreport 7(5):977-980
48. Tatton WG, Chalmers-Redman R, Brown D, Tatton N (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol 53(Suppl 3): S61-S72
49. Taylor EM, Morgan EH (1990) Developmental changes in transferrin and iron uptake by the brain in the rat. Brain Res Dev Brain Res 55(1):35-42 (Pubitemid 20241301)
50. Taylor EM, Crowe A, Morgan EH (1991) Tranferrin and iron uptake by the brain: effects of altered iron status. J Neurochem 57:1584-1592 (Pubitemid 21922793)
51. Troy CM, Salvesen GS (2002) Caspases on the brain. J Neurosci Res 69(2):145-150 (Pubitemid 34734145)
52. Youdim MB, Ben-Shachar D, Riederer P (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov Disord 8(1):1-12 (Pubitemid 23039223)
53. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407(6805):802-809
54. Zecca L, Gallorini M, Schunemann V, Trautwein AX, Gerlach M, Riederer P et al (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 76(6):1766-1773 (Pubitemid 32221116)
55. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5(11):863-873 (Pubitemid 39482155)
56. Zhang S, Wang J, Song N, Xie J, Jiang H (2009) Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenyl-pyridinium (MPP(+)-induced apoptosis in MES23.5 cells. Neurobiol Aging 30(9):1466-1476